QA: Uniqure N V in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001590560_2021_Uniqure_N_V.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001590560, Uniqure N V

  xvar xval
0 AssetsCurrent 258,911,000
1 IntangibleAssetsNetIncludingGoodwill 3,903,000
2 PropertyPlantAndEquipmentNet 32,328,000
3 remainder_Assets 45,253,000
4 LiabilitiesCurrent 27,334,000
5 LiabilitiesNoncurrent 69,156,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,140,710
9 ResearchAndDevelopmentExpense 125,547,741
10 remainder_Expenses 5,774,726
11 remainder_Revenues 30,965,388
12 remainder_NetIncome -63,188,491
13 remainder_ComprehensiveNetIncome 22,291,841
  yvar yval
0 Assets 340,395,000
1 Liabilities 96,490,000
2 Expenses 174,463,177
3 Revenues 30,965,388
4 StockholdersEquity 243,905,000
5 NetIncome -206,686,280
6 ComprehensiveNetIncome -195,540,360
7 BaseVar 363,896,948
8 EconomicCapitalRatiobeforeLimitedLiability 1.54
9 EconomicCapitalRatio 2.71

Edgar->Model Mapping

Feature Distribution

Change over Time